US Patent 8940773 Prolyl hydroxylase inhibitors and methods of use
Patent 8940773 was granted and assigned to Akebia Therapeutics on January, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8940773 Prolyl hydroxylase inhibitors and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
